- Small Modular ImmunoPharmaceuticals
Small Modular ImmunoPharmaceuticals, also knows as SMIPs, is novel class of drugs, a single-chain
polypeptide s, therapeuticantibodies [http://www.bumc.bu.edu/www/busm/itp/PDFs/Hohlbaum1.pdf] . Being one third to half the size of corresponding monoclonal antibodies, they have similar in vivo half life and better tissue penetration properties [http://www.trubion.com/pdf/Trubion_SMIP_Drug_Design.pdf] .References
SMIP, or small modular immunopharmaceutical, therapeutics are single chain polypeptides comprising one binding domain, one hinge domain and one effector domain designed in an effort to meet predetermined therapeutic specifications for specific diseases. SMIP therapeutics are mono-specific (they recognize and attach to single antigen targets and initiate biological activity). Trubion is working on SMIP drug candidates that target validated antigens with the same specificity and predictable biological activity as
mAbs .
Wikimedia Foundation. 2010.